CD4 T cell vaccine and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9821044
SERIAL NO

14535940

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a CD4 T cell vaccine and a use thereof, and provides a CD4 T cell vaccine which can increase intracellular viability and effectively induce an antigen-specific cytotoxic T lymphocyte (CTL) response.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VIGENCELL INC1321HO CATHOLIC UNIV OF KOREA SONGEUI HALL 222 BANPODAERO SEOCHO-GU SEOUL 06591 06591

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cho, Hyun Il Gyeonggi-do, KR 11 52
Kim, Tai Gyu Seoul, KR 16 3
Park, Hye Mi Seoul, KR 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 21, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 21, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00